A message from the PEX PharmaSequence Management Board
Dr. Jarosław Frąckowiak, the current PEX Vice President, became the new President of the PEX PharmaSequence Management Board. The current President, Stefan Bogusławski, will remain at PEX PharmaSequence as the Senior Partner responsible for external and internal strategic consulting. Stefan Bogusławski departed from the position of the President from personal motives, not related to professional activity.
The changes do not imply any adjustments to the PEX strategy. PEX will continue to develop high-quality consulting and innovative analytical and research services on the healthcare market in Poland and in cooperation with foreign PEX Partners.
We are delightet to announce that on the 1st of December 2016 the formal process of merger between PharmaExpert and Sequence has been concluded. A new company under the name PEX PharmaSequence is now operational.13.12.2016